Apotheek Devroe: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Apotheek Devroe
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€280,689
2024 · €399,388-€118,699
Equity
€1.6m
2024 · €1.4m+€279,848
Cash
€594,093
2024 · €357,177+€236,916
Balance sheet total
€4.3m
2024 · €4.2m+€61,355
Largest movements
Assets
- Financial fixed assets -€279,146
down €279,146 (-100%), from €279,146 to €0
- Cash +€236,916
up €236,916 (+66.3%), from €357,177 to €594,093
mainly Net result for the year (+€280,689) and Investment in fixed assets (net) (+€155,306)
- Stocks and contracts +€80,854
up €80,854 (+14.7%), from €550,595 to €631,449
- Receivables within one year +€49,513
up €49,513 (+14.4%), from €342,768 to €392,280
of which Other amounts receivable: +€35,829
Equity and liabilities
- Reserves +€279,848
up €279,848 (+20.8%), from €1.3m to €1.6m
- Debts after one year -€164,589
down €164,589 (-10.1%), from €1.6m to €1.5m
- Other debts -€51,940
down €51,940 (-9.2%), from €565,088 to €513,148
Income statement
- Gross operating margin +€75,798
up €75,798 (+5.9%), from €1.3m to €1.4m
- Staff costs -€28,854
down €28,854 (-5.9%), from €487,023 to €458,169
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€399,388
Gross operating margin
+€75,798
Staff costs
+€28,854
Depreciation
-€12,032
Other operating charges
-€185
Other operating items
-€214,667
Financial income
+€304
Financial charges
+€9,158
Taxes
-€5,928
Result 2025
€280,689
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€264,589
Investment
+€155,306
Financing
-€182,979
Cash 2024
€357,177
From operations (derived)
+€264,589
Net result for the year
+€280,689
Depreciation
+€150,449
Stocks and contracts
-€80,854
Receivables within one year
-€49,513
Smaller working-capital items
+€764
Trade debts
+€10,719
Tax, wage and social debts
+€6,437
Other debts
-€51,940
Accrued charges and deferred income
-€2,163
Investment (derived)
+€155,306
Investment in fixed assets (net)
+€155,306
Financing
-€182,979
Debts after one year
-€164,589
Current portion of long-term debt
-€26,161
Short-term financial debts
+€8,613
Contributions, distributions and other
-€841
Cash 2025
€594,093
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,231,788 | €4,293,143 | +€61,355 | +1.4% |
| Fixed assets | 21/28 | €2,973,182 | €2,667,428 | -€305,754 | -10.3% |
| Tangible fixed assets | 22/27 | €2,694,036 | €2,667,428 | -€26,608 | -1.0% |
| Land and buildings | 22 | €2,269,722 | €2,182,227 | -€87,496 | -3.9% |
| Plant, machinery and equipment | 23 | €248,572 | €311,769 | +€63,198 | +25.4% |
| Furniture and vehicles | 24 | €28,926 | €24,564 | -€4,362 | -15.1% |
| Other tangible fixed assets | 26 | - | €2,052 | +€2,052 | |
| Assets under construction and advance payments | 27 | €146,816 | €146,816 | = | 0.0% |
| Financial fixed assets | 28 | €279,146 | €0 | -€279,146 | -100% |
| Current assets | 29/58 | €1,258,606 | €1,625,715 | +€367,110 | +29.2% |
| Stocks and contracts in progress | 3 | €550,595 | €631,449 | +€80,854 | +14.7% |
| Stocks | 30/36 | €550,595 | €631,449 | +€80,854 | +14.7% |
| Amounts receivable within one year | 40/41 | €342,768 | €392,280 | +€49,513 | +14.4% |
| Trade receivables | 40 | €300,036 | €313,720 | +€13,684 | +4.6% |
| Other amounts receivable | 41 | €42,732 | €78,561 | +€35,829 | +83.8% |
| Cash at bank and in hand | 54/58 | €357,177 | €594,093 | +€236,916 | +66.3% |
| Deferred charges and accrued income | 490/1 | €8,066 | €7,893 | -€173 | -2.1% |
| Total equity and liabilities | 10/49 | €4,231,788 | €4,293,143 | +€61,355 | +1.4% |
| Equity | 10/15 | €1,365,961 | €1,645,808 | +€279,848 | +20.5% |
| Contributions | 10/11 | €20,592 | €20,592 | = | 0.0% |
| Revaluation surpluses | 12 | €2,622 | €2,622 | = | 0.0% |
| Reserves | 13 | €1,342,747 | €1,622,595 | +€279,848 | +20.8% |
| Distributable reserves | 133 | €1,342,747 | €1,622,595 | +€279,848 | +20.8% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €2,865,827 | €2,647,335 | -€218,492 | -7.6% |
| Amounts payable after more than one year | 17 | €1,627,362 | €1,462,773 | -€164,589 | -10.1% |
| Financial debts | 170/4 | €1,627,362 | €1,462,773 | -€164,589 | -10.1% |
| Amounts payable within one year | 42/48 | €1,226,081 | €1,174,341 | -€51,740 | -4.2% |
| Current portion of amounts payable after more than one year | 42 | €190,750 | €164,589 | -€26,161 | -13.7% |
| Financial debts | 43 | €31,721 | €40,334 | +€8,613 | +27.2% |
| Credit institutions | 430/8 | €31,721 | €40,334 | +€8,613 | +27.2% |
| Trade debts | 44 | €267,290 | €278,009 | +€10,719 | +4.0% |
| Suppliers | 440/4 | €267,290 | €278,009 | +€10,719 | +4.0% |
| Advances received on contracts in progress | 46 | €117 | €709 | +€592 | +504% |
| Taxes, remuneration and social security | 45 | €171,114 | €177,551 | +€6,437 | +3.8% |
| Taxes | 450/3 | €100,428 | €107,695 | +€7,267 | +7.2% |
| Remuneration and social security | 454/9 | €70,686 | €69,856 | -€830 | -1.2% |
| Other amounts payable | 47/48 | €565,088 | €513,148 | -€51,940 | -9.2% |
| Accrued charges and deferred income | 492/3 | €12,383 | €10,220 | -€2,163 | -17.5% |
| Remuneration, social security and pensions | 62 | €487,023 | €458,169 | -€28,854 | -5.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €138,417 | €150,449 | +€12,032 | +8.7% |
| Other operating charges | 640/8 | €10,111 | €10,296 | +€185 | +1.8% |
| Non-recurring operating charges | 66A | €477 | €215,144 | +€214,667 | +45,034% |
| Gross operating margin | 9900 | €1,282,566 | €1,358,364 | +€75,798 | +5.9% |
| Operating profit (loss) | 9901 | €646,538 | €524,306 | -€122,232 | -18.9% |
| Financial income | 75/76B | €8,395 | €8,699 | +€304 | +3.6% |
| Recurring financial income | 75 | €8,395 | €8,699 | +€304 | +3.6% |
| Financial charges | 65/66B | €69,465 | €60,307 | -€9,158 | -13.2% |
| Recurring financial charges | 65 | €69,465 | €60,307 | -€9,158 | -13.2% |
| Profit (loss) for the period before taxes | 9903 | €585,468 | €472,697 | -€112,771 | -19.3% |
| Income taxes | 67/77 | €186,081 | €192,009 | +€5,928 | +3.2% |
| Profit (loss) for the period | 9904 | €399,388 | €280,689 | -€118,699 | -29.7% |
| Profit (loss) for the period to be appropriated | 9905 | €399,388 | €280,689 | -€118,699 | -29.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.